Sign in to view content

Severity of Diabetic Retinopathy as an Independent Risk Factor for Cerebral Vascular Accidents, Myocardial Infarctions, and All-Cause Mortality

Bobeck S Modjtahedi, MD

Video
Published 2020

Related

Bevacizumab-First vs Real-World Cost Outcomes for Diabetic Macular Edema: 2-Year Cost Analysis Modeled on DRCR Protocol AC Results
Dilraj S Grewal, MD, FASRS
Annual Meeting Talks
2023
Optimizing Oral Fluorescein Angiography: A Comparative Study Evaluating Concentrations and Efficacy in Retinal Imaging
Guillermo Salcedo-Villanueva, MD
Annual Meeting Talks
2024
Impact of Delayed Treatment in Diabetic Retinal Disease: Experience From VISTA/VIVID and PANORAMA
Sunil Srivastava, MD
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more